RecruitingChronic Low-back PainVertebrogenic Pain Syndrome
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Eligible age
18+ yrs
Accepts
All genders
Locations
17 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
Sponsor: Boston Scientific Corporation
You may qualify if…
- ✓ Study candidate is scheduled to be treated with a commercially approved Intracept™ Intraosseous Nerve Ablation System per local Instructions for Use (IFU).
- ✓ Signed a valid, IRB/EC-approved informed consent form.
You may not qualify if…
- ✕ Meets any contraindications per locally applicable Instructions for Use (IFU).
Where it's recruiting
Arizona
Flagstaff · Phoenix
California
Larkspur
Connecticut
Westport
District of Columbia
Washington D.C.
Florida
Orlando
Georgia
Jasper
Idaho
Post Falls
Illinois
Barrington
Kentucky
Lexington
Louisiana
New Orleans
Minnesota
Maple Grove
New York
Port Jefferson Station · Rochester
Source: ClinicalTrials.gov · NCT06827262 · last updated 2026-08-11